Defense Health Agency Contracting Activity - DHACA
· Federal agency
DoD Tick-Borne Disease, Idea Development Award
The FY22 TBDRP Idea Development Award is intended to support research that could lead to impactful discoveries or significant advancements that will accelerate progress toward reducing the burden of Lyme disease and/or o...
82
match
Deadline1396 days agoLocationAlabamaTypegrantLevelFederalClosedposted Apr 11, 2022
✦ AI Summary
Who can apply: Federal-level applicants (see eligibility for details).
Funding amount: total funding pool ~$2,080,000.
Next deadline: August 25, 2022.
Issued by: Defense Health Agency Contracting Activity - DHACA.
The “key facts” mode pulls structured fields directly from the official source posting (amount, deadline, eligibility tags). The AI mode adds a short plain-English narrative on top, generated from the same source. Always verify with the agency before applying.
AI-generated. Always verify with the official source.
Deadline
1396 days ago
Aug 25, 2022
Total pool
$2.1M
About this opportunity
The FY22 TBDRP Idea Development Award is intended to support research that could lead to impactful discoveries or significant advancements that will accelerate progress toward reducing the burden of Lyme disease and/or other tick-borne diseases and conditions and improve patient care, and/or the quality of life for military Service their beneficiaries, as well as the American public.This research should be conceptually innovative, introduce a new concept or question, challenge existing paradigms, approach issues from a new perspective, or exhibit other uniquely creative qualities and should not merely be an incremental advance upon published data. Applications must describe the short- and long-term impact of the proposed research, as well as the evidence-based burden of disease on public health. This award mechanism promotes basic through translational research, including preclinical and clinical research, as well as correlative studies associated with an existing clinical trial to establish proof-of-principle for further development in future studies.Research involving human subjects and human anatomical substances is permitted; however, clinical trials are not allowed under this program announcement.Leveraging existing resources, maximizing statistical power, and using validated specimens from Lyme and other tick-borne disease biorepositories and databases are encouraged, but not required. Investigators are strongly encouraged to incorporate the following components into their study design where appropriate: authentication of proposed cell lines; statistical rigor of in vitro cellular studies and preclinical animal experiments; and validation in well-pedigreed cohorts of uniformly documented patients. Studies utilizing data derived from large patient studies that include long-term health records, biospecimen repositories, and pre-existing research and/or studies that apply state-of-the art genomic and/or proteomic analysis, bioinformatics, and/or mathematical models to such data are also encouraged. The criteria defining the inclusion/exclusion of curated biospecimens or data in biorepositories or databases must be described to demonstrate the validity of their use in the proposed studies.A Career Development Option is available to eligible early-career investigators who propose to conduct impactful research under the mentorship of an experienced tick-borne disease researcher. The Idea Development Award – Career Development Option has a lower direct cost limit than the Idea Development Award; however, preliminary data are not required. Applications submitted under the Idea Development Award – Career Development Option will be reviewed via separate, career development-specific evaluation criteria by a separate, dedicated peer review panel. The following are key aspects of the Career Development Option:• Principal Investigator (PI): The PI must be an early-career research scientist, physician scientist, or other qualified clinical scientist within 10 years of completing their terminal degree (excluding time spent in residency or on family medical leave). The PI’s record of accomplishments and the proposed research will be evaluated regarding their potential for contributing to the field of tick-borne disease research. Because career development is the focus of this award, the PI’s institution should demonstrate a commitment to the PI through a minimum of 75% protected research time for all tick-borne disease research projects by the PI, although more protected time is highly desirable.• Mentorship: The mentor must be an experienced tick-borne disease researcher, as demonstrated by a recent (last 5 years) history of funding and publications in tick-borne disease research, and should ideally have experience mentoring other independent scientists. Collectively, the PI/mentorship team should have demonstrated experience in the field (pathogen/disease and associated methods) of the proposed studies.
Read the agency's eligibility checklist before you start — it's almost always shorter than the full NOFO and will tell you in 90 seconds whether to keep going.
Need help getting in touch with the right agency contact?
Create a free account and our specialists will guide you through the application end-to-end.